Ghana becomes first country to approve Oxford malaria vaccine for children

  • Ghana has made history by becoming the first country to approve a highly effective malaria vaccine developed by scientists at the University of Oxford in the UK.
  • The vaccine, called R21/Matrix-M, has exceeded the World Health Organization’s target of 75% efficacy, making it a significant milestone in the fight against malaria. The R21/Matrix-M Vaccine Targets the.
    Plasmodium ‘Sporozoite’.
  • According to the World Health Organization (WHO), an estimated 619,000 people died from malaria in 2021, with the vast majority of the deaths being children in sub-Saharan Africa.
  • In Ghana, where malaria is endemic and perennial, an estimated 5.3 million cases and 12,500 deaths were recorded in 2021, The R21/Matrix-M vaccine, which has shown promising results in clinical trials.